From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
Forest
Forest Laboratories was acquired in July 2014 by Dublin, Ireland-based drugmaker Actavis. In September 2010, one of its subsidiaries, Forest Pharmaceuticals, pleaded guilty and agreed to pay $313 million related to a host of misconduct allegations involving three drugs.
Forest Laboratories began reporting payments for consulting, speaking, meals, travel and educational items as of January 2012. It also reports research payments in a separate report.
Forest's 2013 U.S. sales: $3.8 billion. Source: IMS Health.
See all Forest payments, or visit Forest's transparency page.
Notable drugs
Payment Reports
2012 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Speaking | $10,081,469 | $40,325,874 |
Meals | $3,032,478 | $12,129,912 |
Travel | $1,065,428 | $4,261,713 |
Consulting | $282,717 | $1,130,869 |
Items, Gifts | $30,152 | $120,608 |
Adjustment | -$1,038 | -$4,152 |
$14,491,206 | $57,964,824 |
2012 Jan. to Dec. Research
Avg. Quarterly | Total | |
---|---|---|
Research | $10,332,106 | $41,328,424 |
$10,332,106 | $41,328,424 |
2013 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Speaking | $8,064,983 | $32,259,930 |
Meals | $2,531,305 | $10,125,222 |
Travel | $963,398 | $3,853,592 |
Consulting | $483,620 | $1,934,481 |
Other | $150,878 | $603,512 |
Items, Gifts | $58,884 | $235,537 |
$12,253,068 | $49,012,274 |
2013 Jan. to Dec. Research
Avg. Quarterly | Total | |
---|---|---|
Research | $15,129,492 | $60,517,970 |
$15,129,492 | $60,517,970 |
Total Payments by State
State | Total |
---|---|
California | $24,273,457 |
Florida | $23,673,143 |
New York | $13,818,512 |
Texas | $13,653,734 |
New Jersey | $9,528,946 |
Pennsylvania | $8,930,725 |
Ohio | $8,734,881 |
Illinois | $7,551,325 |
Massachusetts | $6,824,783 |
Georgia | $6,373,612 |
Michigan | $6,029,598 |
North Carolina | $5,558,260 |
Indiana | $5,434,627 |
Virginia | $3,973,562 |
Washington | $3,891,917 |
Missouri | $3,843,798 |
Wisconsin | $3,466,011 |
Oklahoma | $3,464,799 |
Tennessee | $3,435,404 |
Connecticut | $3,305,634 |
Arizona | $3,299,117 |
Maryland | $3,255,052 |
Oregon | $2,989,660 |
Colorado | $2,874,055 |
Alabama | $2,715,517 |
Louisiana | $2,581,261 |
Kansas | $2,445,724 |
Utah | $2,283,720 |
Kentucky | $2,126,656 |
South Carolina | $2,066,658 |
Nevada | $1,894,751 |
Nebraska | $1,820,565 |
Mississippi | $1,395,003 |
Iowa | $1,298,123 |
Arkansas | $1,272,585 |
New Mexico | $1,227,825 |
Rhode Island | $1,035,246 |
Minnesota | $932,942 |
West Virginia | $897,097 |
District of Columbia | $879,872 |
Idaho | $724,878 |
New Hampshire | $597,303 |
Delaware | $585,982 |
Hawaii | $366,740 |
Puerto Rico | $346,467 |
Maine | $331,532 |
South Dakota | $275,609 |
North Dakota | $223,875 |
Vermont | $124,055 |
Montana | $113,415 |
Alaska | $43,877 |
Wyoming | $29,234 |
[Unknown State] | $2,369 |
What Companies Disclose
See which services pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.